TrialScientific reports2019

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.

Mariya Rozenblit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.